1-(4-((4aS,8aS)-2,5,5,8a-Tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)butane-2-yl)guanidine compound with antiproliferative and cytotoxic properties

The invention relates to chemistry and medicine, in particular to a compound with hybrid terpene-guanidine skeleton and can be used for treating cancer.Summary of the invention consists in that the compound 1-(4-((4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)butane-2-yl)...

Full description

Saved in:
Bibliographic Details
Main Authors ARÎCU Aculina, UNGUR Nicon, SECARA Elena, BARBA Alic, KUCHKOVA Kaleria, DRAGALIN Ion, DUCA Gheorghe
Format Patent
LanguageEnglish
Romanian
Russian
Published 31.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to chemistry and medicine, in particular to a compound with hybrid terpene-guanidine skeleton and can be used for treating cancer.Summary of the invention consists in that the compound 1-(4-((4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)butane-2-yl)guanidine is claimed for use as a compound with antiproliferative and cytotoxic properties. Invenţia se referă la chimie şi medicină, în special la un compus cu schelet hibrid terpenic şi guanidinic şi poate fi utilizat pentru tramentul cancerului.Esenţa invenţiei constă în aceea că se revendică compusul 1-(4-((4aS,8aS)-2,5,5,8a-tetrametil-3,4,4a,5,6,7,8,8a-octahidronaftalen-1-il)butan-2-il)guanidină pentru utilizare în calitate de compus cu activitate antiproliferativă şi citotoxică. Изобретение относится к химии и медицине, в частности к соединению с гибридным терпеново-гуанидиновым скелетом и может быть использовано для лечения рака.Сущность изобретения состоит в том, что заявляется соединение 1-(4-((4aS,8aS)-2,5,5,8a-тетраметил-3,4,4a,5,6,7,8,8a-октагидро-нафталин-1-ил)бутан-2-ил)гуанидин для использования в качестве соединения с антипролиферативными и цитотоксическими свойствами.
Bibliography:Application Number: MD20180000006